FDA Clears Magstim Transcranial Magnetic Stimulation for Obsessive Compulsive Disorder
(Minneapolis, MN) — Jan. 18, 2023 — Magstim, a global leader in neuroscience research and Transcranial Magnetic Stimulation (TMS) solutions for mental health, announced today that the FDA has cleared the Horizon 3.0 (with or without StimGuide+) and E-z Cool Coil to treat adult patients diagnosed with Obsessive Compulsive Disorder (OCD) as well as Major Depressive Disorder (MDD). This indication offers non-invasive treatment for OCD in adult patients as an